Publications for Anna Ansell
Co-author map based on ISI articles 2007-
Publications mentioned in social media 2 times*
Keywordstumors treatment squamous sensitivity response neck lines hnscc head genes factors expression egfr cisplatin cetuximab cells cell carcinoma cancer cafs
|Anna Ansell, Adam Jedlinski, Ann-Charlotte Johansson and Karin Roberg|
Epidermal growth factor is a biomarker for poor cetuximab response in tongue cancer cells
Journal of Oral Pathology & Medicine, 2016, 45(1), 9-16.
|Lovisa Farnebo, Annika Stjernstrom, Mats Fredrikson, Anna Ansell, Stina Garvin and Lena Thunell|
DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck
DNA Repair, 2015, 31, 64-72.
Web of Science® Times Cited: 2
|Lovisa Farnebo, Katharina Tiefenböck, Anna Ansell, Lena Thunell, Stina Garvin and Karin Roberg|
Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients
International Journal of Cancer, 2013, 133(8), 1994-2003.
Web of Science® Times Cited: 12
|Adam Jedlinski, Anna Ansell, Ann-Charlotte Johansson and Karin Roberg|
EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines
Journal of Oral Pathology & Medicine, 2013, 42(1), 26-36.
Web of Science® Times Cited: 15
|Ann-Charlotte Johansson, Anna Ansell, Fredrik Jerhammar, Maja Bradic Lindh, Reidar Grenman, Eva Munck-Wikland, Arne Ostman and Karin Roberg|
Cancer-Associated Fibroblasts Induce Matrix Metalloproteinase-Mediated Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cells
Molecular Cancer Research, 2012, 10(9), 1158-1168.
Web of Science® Times Cited: 23
|Ola Wahlström, Cecilia Linder, Anna Ansell, Anders Kalén, Mats Söderström and Per Magnusson|
Acidic preparations of lysed platelets upregulate proliferative pathways in osteoblast-like cells as demonstrated by genome-wide microarray analysis
Platelets, 2011, 22(6), 452-460.
Web of Science® Times Cited: 1
|Anna Ansell, Fredrik Jerhammar, Rebecca Ceder, Roland Grafström, Reidar Grénman and Karin Roberg|
Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines.
Oral Oncology, 2009, 45(10), 866-871.
Web of Science® Times Cited: 7
|Lovisa Farnebo, Adam Jedlinski, Anna Ansell, Linda Vainikka, Lena Thunell, Reidar Grenman, Ann-Charlotte Johansson and Karin Roberg|
Proteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell lines
International Journal of Molecular Medicine, 2009, 24(4), 549-556.
Web of Science® Times Cited: 15
|Anna Ansell, Lovisa Farnebo, Reidar Grénman, Karin Roberg and Lena Thunell|
Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer
Oral Oncology, 2009, 45(1), 23-29.
Web of Science® Times Cited: 21
|Ola Wahlström, Olof Risto, Anders Kalén, Cecilia Linder, Anna Ansell, Mats Söderström and Per Magnusson|
Acidic preparations of lysed platelets up-regulate proliferative and vascular genes, and the TGFBR pathway in osteoblast-like cells in BONE, vol 48, issue , pp S118-S118
|A Johansson, Anna Ansell, A Ostman and Karin Roberg|
Cancer-associated fibroblasts desensitizes head and neck squamous cell carcinoma cells to epidermal growth factor receptor-targeted therapy in EJC SUPPLEMENTS, vol 8, issue 5, pp 134-134
EJC SUPPLEMENTS, 2010.
|Anna Ansell, Fredrik Jerhammar, R Ceder, R Grenman and Karin Roberg|
Matrix metalloproteinase-7 and-13 predict response to cisplatin in head and neck cancer in ORAL ONCOLOGY, vol , issue , pp 94-94
ORAL ONCOLOGY, 2009.
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.